Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial
Tricia M. McKeever(University of Nottingham), Rebecca Haydock(Nottingham Biomedical Research Centre), Bernard Higgins(Newcastle upon Tyne Hospital), Eleanor Mitchell(University of Nottingham), Graham Devereux(Nottingham Biomedical Research Centre), Richard Swinden(University of Nottingham), Janet Oborne(University of Nottingham), Christopher E. Brightling(NIHR Leicester Biomedical Research Centre), David Price(Optimum Therapeutics (United States)), Lelia Duley(National Milk Records (United Kingdom)), Lucy Bradshaw(University of Nottingham), Mike Thomas(University of Southampton), Samantha Walker(Asthma UK), Ian Pavord(Oxford BioMedica (United Kingdom)), Andrew Skeggs(University Hospitals of Derby and Burton NHS Foundation Trust), Andrew Wilson(University of Leicester), Tim Harrison(University of Nottingham), Kevin Mortimer(University of Nottingham)
Cited by 1
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
|Journal of Allergy and Clinical Immunology|2010|746
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Practical guide to skin prick tests in allergy to aeroallergens
|Allergy|2011|648